Akebia’s experimental pill meets anemia, heart-safety goals in two late-stage clinical trials,

Akebia Therapeutics said Tuesday that its experimental anemia pill achieved the primary efficacy and heart-safety goals in two pivotal Phase 3 clinical …, Akebia Therapeutics said Tuesday that its experimental anemia pill achieved the primary efficacy and heart-safety goals in two pivotal Phase 3 clinical …, Read More